Pathophysiology of the upper gastrointestinal tract in the critically ill patient

Rationale for the therapeutic benefits of acid suppression

Research output: Contribution to journalArticle

121 Citations (Scopus)

Abstract

Gastric mucosal damage occurs in critically ill patients in intensive care units and develops in the setting of severe physiologic stress. Within 24 hrs of admission to the intensive care unit, 75% to 100% of critically ill patients demonstrate evidence of stress-related mucosal disease. Stress ulcers present a risk of clinically important bleeding, which is associated with alterations in physiology, such as hypotension or tachycardia, or results in anemia or the need for transfusion. Clinically important bleeding occurs in approximately 1% to 4% of critically ill patients. The pathophysiology of stress-related mucosal disease is complex. Major factors responsible for stress ulcer are decreased blood flow, mucosal ischemia, and hypoperfusion and reperfusion injury. Acid-suppressive regimens that elevate the intragastric pH and maintain the pH over time have the potential to prevent stress-related mucosal disease. Intragastric pH studies have demonstrated that, whereas a pH of >4 may be adequate to prevent stress ulceration, a pH of >6 may be necessary to maintain clotting in patients at risk of rebleeding from peptic ulcer. Studies comparing the ability of intravenous administrations of histamine-2-receptor antagonists and proton pump inhibitors to raise and maintain intragastric pH suggest that, although both can raise the pH to >4, proton pump inhibitors are much more likely to maintain this pH. Unlike histamine-2-receptor antagonists, proton pump inhibitors can elevate and maintain the intragastric pH at >6. This is relevant for patients in the intensive care unit at risk for rebleeding from peptic ulcers after hemostasis.

Original languageEnglish (US)
JournalCritical Care Medicine
Volume30
Issue number6 SUPPL.
StatePublished - 2002

Fingerprint

Upper Gastrointestinal Tract
Critical Illness
Acids
Proton Pump Inhibitors
Intensive Care Units
Histamine Receptors
Therapeutics
Peptic Ulcer
Ulcer
Hemorrhage
Hemostasis
Reperfusion Injury
Tachycardia
Intravenous Administration
Hypotension
Anemia
Stomach

Keywords

  • Acid-suppressive drugs
  • Clinically important bleeding
  • Critically ill patients
  • Gastrointestinal hemorrhage
  • Histamine-2-receptor antagonists
  • Intensive care unit
  • Intragastric pH
  • Intravenous
  • Pathophysiology
  • Prophylaxis
  • Proton pump inhibitors
  • Stress ulcers

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

@article{72539e1c5f2f433cb200e2f9dd758327,
title = "Pathophysiology of the upper gastrointestinal tract in the critically ill patient: Rationale for the therapeutic benefits of acid suppression",
abstract = "Gastric mucosal damage occurs in critically ill patients in intensive care units and develops in the setting of severe physiologic stress. Within 24 hrs of admission to the intensive care unit, 75{\%} to 100{\%} of critically ill patients demonstrate evidence of stress-related mucosal disease. Stress ulcers present a risk of clinically important bleeding, which is associated with alterations in physiology, such as hypotension or tachycardia, or results in anemia or the need for transfusion. Clinically important bleeding occurs in approximately 1{\%} to 4{\%} of critically ill patients. The pathophysiology of stress-related mucosal disease is complex. Major factors responsible for stress ulcer are decreased blood flow, mucosal ischemia, and hypoperfusion and reperfusion injury. Acid-suppressive regimens that elevate the intragastric pH and maintain the pH over time have the potential to prevent stress-related mucosal disease. Intragastric pH studies have demonstrated that, whereas a pH of >4 may be adequate to prevent stress ulceration, a pH of >6 may be necessary to maintain clotting in patients at risk of rebleeding from peptic ulcer. Studies comparing the ability of intravenous administrations of histamine-2-receptor antagonists and proton pump inhibitors to raise and maintain intragastric pH suggest that, although both can raise the pH to >4, proton pump inhibitors are much more likely to maintain this pH. Unlike histamine-2-receptor antagonists, proton pump inhibitors can elevate and maintain the intragastric pH at >6. This is relevant for patients in the intensive care unit at risk for rebleeding from peptic ulcers after hemostasis.",
keywords = "Acid-suppressive drugs, Clinically important bleeding, Critically ill patients, Gastrointestinal hemorrhage, Histamine-2-receptor antagonists, Intensive care unit, Intragastric pH, Intravenous, Pathophysiology, Prophylaxis, Proton pump inhibitors, Stress ulcers",
author = "Fennerty, {M (Brian)}",
year = "2002",
language = "English (US)",
volume = "30",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "6 SUPPL.",

}

TY - JOUR

T1 - Pathophysiology of the upper gastrointestinal tract in the critically ill patient

T2 - Rationale for the therapeutic benefits of acid suppression

AU - Fennerty, M (Brian)

PY - 2002

Y1 - 2002

N2 - Gastric mucosal damage occurs in critically ill patients in intensive care units and develops in the setting of severe physiologic stress. Within 24 hrs of admission to the intensive care unit, 75% to 100% of critically ill patients demonstrate evidence of stress-related mucosal disease. Stress ulcers present a risk of clinically important bleeding, which is associated with alterations in physiology, such as hypotension or tachycardia, or results in anemia or the need for transfusion. Clinically important bleeding occurs in approximately 1% to 4% of critically ill patients. The pathophysiology of stress-related mucosal disease is complex. Major factors responsible for stress ulcer are decreased blood flow, mucosal ischemia, and hypoperfusion and reperfusion injury. Acid-suppressive regimens that elevate the intragastric pH and maintain the pH over time have the potential to prevent stress-related mucosal disease. Intragastric pH studies have demonstrated that, whereas a pH of >4 may be adequate to prevent stress ulceration, a pH of >6 may be necessary to maintain clotting in patients at risk of rebleeding from peptic ulcer. Studies comparing the ability of intravenous administrations of histamine-2-receptor antagonists and proton pump inhibitors to raise and maintain intragastric pH suggest that, although both can raise the pH to >4, proton pump inhibitors are much more likely to maintain this pH. Unlike histamine-2-receptor antagonists, proton pump inhibitors can elevate and maintain the intragastric pH at >6. This is relevant for patients in the intensive care unit at risk for rebleeding from peptic ulcers after hemostasis.

AB - Gastric mucosal damage occurs in critically ill patients in intensive care units and develops in the setting of severe physiologic stress. Within 24 hrs of admission to the intensive care unit, 75% to 100% of critically ill patients demonstrate evidence of stress-related mucosal disease. Stress ulcers present a risk of clinically important bleeding, which is associated with alterations in physiology, such as hypotension or tachycardia, or results in anemia or the need for transfusion. Clinically important bleeding occurs in approximately 1% to 4% of critically ill patients. The pathophysiology of stress-related mucosal disease is complex. Major factors responsible for stress ulcer are decreased blood flow, mucosal ischemia, and hypoperfusion and reperfusion injury. Acid-suppressive regimens that elevate the intragastric pH and maintain the pH over time have the potential to prevent stress-related mucosal disease. Intragastric pH studies have demonstrated that, whereas a pH of >4 may be adequate to prevent stress ulceration, a pH of >6 may be necessary to maintain clotting in patients at risk of rebleeding from peptic ulcer. Studies comparing the ability of intravenous administrations of histamine-2-receptor antagonists and proton pump inhibitors to raise and maintain intragastric pH suggest that, although both can raise the pH to >4, proton pump inhibitors are much more likely to maintain this pH. Unlike histamine-2-receptor antagonists, proton pump inhibitors can elevate and maintain the intragastric pH at >6. This is relevant for patients in the intensive care unit at risk for rebleeding from peptic ulcers after hemostasis.

KW - Acid-suppressive drugs

KW - Clinically important bleeding

KW - Critically ill patients

KW - Gastrointestinal hemorrhage

KW - Histamine-2-receptor antagonists

KW - Intensive care unit

KW - Intragastric pH

KW - Intravenous

KW - Pathophysiology

KW - Prophylaxis

KW - Proton pump inhibitors

KW - Stress ulcers

UR - http://www.scopus.com/inward/record.url?scp=0036270487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036270487&partnerID=8YFLogxK

M3 - Article

VL - 30

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 6 SUPPL.

ER -